{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T01:32:04Z","timestamp":1791941524611,"version":"4.3.4"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81472886"],"award-info":[{"award-number":["81472886"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81172588"],"award-info":[{"award-number":["81172588"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.lfs.2019.117115","type":"journal-article","created":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T11:12:51Z","timestamp":1575025971000},"page":"117115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"special_numbering":"C","title":["The potential of Diosgenin in treating psoriasis: Studies from HaCaT keratinocytes and imiquimod-induced murine model"],"prefix":"10.1016","volume":"241","author":[{"given":"Shidi","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjie","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kehao","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changzheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.lfs.2019.117115_bb0005","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/jid.2012.339","article-title":"Global epidemiology of psoriasis: a systematic review of incidence and prevalence","volume":"133","author":"Parisi","year":"2013","journal-title":"J. Invest. Dermatol."},{"issue":"2","key":"10.1016\/j.lfs.2019.117115_bb0010","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/jdv.13854","article-title":"A systematic review of worldwide epidemiology of psoriasis","volume":"31","author":"Michalek","year":"2017","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"14","key":"10.1016\/j.lfs.2019.117115_bb0015","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1001\/jama.296.14.1735","article-title":"Risk of myocardial infarction in patients with psoriasis","volume":"296","author":"Gelfand","year":"2006","journal-title":"Jama"},{"issue":"6","key":"10.1016\/j.lfs.2019.117115_bb0020","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1067\/mjd.2003.540","article-title":"Connections between psoriasis and Crohn\u2019s disease","volume":"48","author":"Najarian","year":"2003","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.lfs.2019.117115_bb0025","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3389\/fimmu.2018.00579","article-title":"Systemic inflammation and cardiovascular comorbidity in psoriasis patients: causes and consequences","volume":"9","author":"Boehncke","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2019.117115_bb0030","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1146\/annurev-pathol-011811-132448","article-title":"Psoriasis","volume":"7","author":"Perera","year":"2012","journal-title":"Annu. Rev. Pathol."},{"issue":"9997","key":"10.1016\/j.lfs.2019.117115_bb0035","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","article-title":"Psoriasis","volume":"386","author":"Boehncke","year":"2015","journal-title":"Lancet"},{"issue":"7162","key":"10.1016\/j.lfs.2019.117115_bb0040","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nature06116","article-title":"Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide","volume":"449","author":"Lande","year":"2007","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.lfs.2019.117115_bb0045","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1346-8138.2011.01483.x","article-title":"Antimicrobial peptides in the pathogenesis of psoriasis","volume":"39","author":"Morizane","year":"2012","journal-title":"J. Dermatol."},{"issue":"5","key":"10.1016\/j.lfs.2019.117115_bb0050","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1365-2133.1991.tb14774.x","article-title":"Psoriasis induced by interferon-alpha","volume":"125","author":"Funk","year":"1991","journal-title":"Br. J. Dermatol."},{"issue":"5","key":"10.1016\/j.lfs.2019.117115_bb0055","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/sj.jid.5701213","article-title":"Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells","volume":"128","author":"Lowes","year":"2008","journal-title":"J. Invest. Dermatol."},{"issue":"10","key":"10.1016\/j.lfs.2019.117115_bb0060","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1111\/jdv.14433","article-title":"The role of IL-23 and the IL-23\/TH 17 immune axis in the pathogenesis and treatment of psoriasis","volume":"31","author":"Girolomoni","year":"2017","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"1","key":"10.1016\/j.lfs.2019.117115_bb0065","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/BOR.0000000000000358","article-title":"Pathogenesis and immunotherapy in cutaneous psoriasis","volume":"29","author":"Alexander","year":"2017","journal-title":"Curr. Opin. Rheumatol."},{"issue":"1","key":"10.1016\/j.lfs.2019.117115_bb0070","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jaad.2013.12.036","article-title":"Interleukin 17A: toward a new understanding of psoriasis pathogenesis","volume":"71","author":"Lynde","year":"2014","journal-title":"J. Am. Acad. Dermatol."},{"issue":"6","key":"10.1016\/j.lfs.2019.117115_bb0075","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.4049\/jimmunol.1800013","article-title":"Discovery of the IL-23\/IL-17 Signaling Pathway and the Treatment of Psoriasis","volume":"201","author":"Hawkes","year":"2018","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.lfs.2019.117115_bb0080","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nrd1607","article-title":"Psoriasis: emerging therapeutic strategies","volume":"4","author":"Gottlieb","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.lfs.2019.117115_bb0085","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00403-006-0660-6","article-title":"The long-term efficacy and safety of new biological therapies for psoriasis","volume":"298","author":"Papp","year":"2006","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.lfs.2019.117115_bb0090","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/561018","article-title":"Mechanisms of action of topical corticosteroids in psoriasis","volume":"2012","author":"Uva","year":"2012","journal-title":"Int. J. Endocrinol."},{"issue":"8","key":"10.1016\/j.lfs.2019.117115_bb0095","first-page":"578","article-title":"Advances in the pharmacological activities and mechanisms of diosgenin","volume":"13","author":"Chen","year":"2015","journal-title":"Chin. J. Nat. Med."},{"issue":"10","key":"10.1016\/j.lfs.2019.117115_bb0100","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/s41419-018-1099-3","article-title":"Diosgenin promotes antitumor immunity and PD-1 antibody efficacy against melanoma by regulating intestinal microbiota","volume":"9","author":"Dong","year":"2018","journal-title":"Cell Death Dis."},{"issue":"6","key":"10.1016\/j.lfs.2019.117115_bb0105","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1021\/np900690z","article-title":"Diosgenin, a plant-derived sapogenin, enhances regulatory T-cell immunity in the intestine of mice with food allergy","volume":"73","author":"Huang","year":"2010","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.lfs.2019.117115_bb0110","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.biopha.2016.12.068","article-title":"Diosgenin ameliorates development of neuropathic pain in diabetic rats: involvement of oxidative stress and inflammation","volume":"86","author":"Kiasalari","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"6","key":"10.1016\/j.lfs.2019.117115_bb0115","doi-asserted-by":"crossref","first-page":"4938","DOI":"10.3390\/nu7064938","article-title":"In vivo protective effects of diosgenin against doxorubicin-induced Cardiotoxicity","volume":"7","author":"Chen","year":"2015","journal-title":"Nutrients"},{"issue":"5","key":"10.1016\/j.lfs.2019.117115_bb0120","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/s41422-018-0018-6","article-title":"Anti-mitotic chemotherapeutics promote apoptosis through TL1A-activated death receptor 3 in cancer cells","volume":"28","author":"Qi","year":"2018","journal-title":"Cell Res."},{"key":"10.1016\/j.lfs.2019.117115_bb0125","first-page":"S14","article-title":"The skin in psoriasis: assessment and challenges","volume":"33","author":"Oji","year":"2015","journal-title":"Clin. Exp. Rheumatol."},{"issue":"1","key":"10.1016\/j.lfs.2019.117115_bb0130","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.cyto.2012.06.316","article-title":"IL-22 induced cell proliferation is regulated by PI3K\/Akt\/mTOR signaling cascade","volume":"60","author":"Mitra","year":"2012","journal-title":"Cytokine"},{"issue":"2","key":"10.1016\/j.lfs.2019.117115_bb0135","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1365-2567.2004.01976.x","article-title":"Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4","volume":"113","author":"P\u00e5lsson-McDermott","year":"2004","journal-title":"Immunology"},{"issue":"3","key":"10.1016\/j.lfs.2019.117115_bb0140","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/jid.2010.340","article-title":"Integrative responses to IL-17 and TNF-\u03b1 in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis","volume":"131","author":"Chiricozzi","year":"2011","journal-title":"J. Invest. Dermatol."},{"issue":"2 Pt 1","key":"10.1016\/j.lfs.2019.117115_bb0145","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1067\/mjd.2000.106374","article-title":"Two considerations for patients with psoriasis and their clinicians: what defines mild, moderate, and severe psoriasis? What constitutes a clinically significant improvement when treating psoriasis","volume":"43","author":"Krueger","year":"2000","journal-title":"J. Am. Acad. Dermatol."},{"issue":"1","key":"10.1016\/j.lfs.2019.117115_bb0150","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10103-017-2360-1","article-title":"A clinical review of phototherapy for psoriasis","volume":"33","author":"Zhang","year":"2018","journal-title":"Lasers Med. Sci."},{"issue":"6","key":"10.1016\/j.lfs.2019.117115_bb0155","first-page":"586","article-title":"Severe and acute complications of biologics in psoriasis","volume":"152","author":"Oussedik","year":"2017","journal-title":"G. Ital. Dermatol. Venereol."},{"issue":"2","key":"10.1016\/j.lfs.2019.117115_bb0160","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.immuni.2004.07.007","article-title":"IL-22 increases the innate immunity of tissues","volume":"21","author":"Wolk","year":"2004","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.lfs.2019.117115_bb0165","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1038\/sj.jid.5700310","article-title":"Prominent production of IL-20 by CD68+\/CD11c+ myeloid-derived cells in psoriasis: gene regulation and cellular effects","volume":"126","author":"Wang","year":"2006","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.lfs.2019.117115_bb0170","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cytogfr.2014.10.009","article-title":"An inflammatory triangle in psoriasis: TNF, type I IFNs and IL-17","volume":"26","author":"Grine","year":"2015","journal-title":"Cytokine Growth Factor Rev."},{"issue":"1\u20132","key":"10.1016\/j.lfs.2019.117115_bb0175","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2016.12.012","article-title":"30 years of NF-\u03baB: a blossoming of relevance to human pathobiology","volume":"168","author":"Zhang","year":"2017","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.lfs.2019.117115_bb0180","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.cytogfr.2008.01.006","article-title":"IkappaB kinase beta (IKKbeta\/IKK2\/IKBKB)\u2014a key molecule in signaling to the transcription factor NF-kappaB","volume":"19","author":"Schmid","year":"2008","journal-title":"Cytokine Growth Factor Rev."},{"issue":"8","key":"10.1016\/j.lfs.2019.117115_bb0185","doi-asserted-by":"crossref","first-page":"5785","DOI":"10.1128\/MCB.19.8.5785","article-title":"NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1","volume":"19","author":"Guttridge","year":"1999","journal-title":"Mol. Cell. Biol."},{"issue":"1","key":"10.1016\/j.lfs.2019.117115_bb0190","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1083\/jcb.134.1.13","article-title":"Bcl-2 down-regulates the activity of transcription factor NF-kappaB induced upon apoptosis","volume":"134","author":"Grimm","year":"1996","journal-title":"J. Cell Biol."},{"issue":"1","key":"10.1016\/j.lfs.2019.117115_bb0195","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nm1162","article-title":"Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model","volume":"11","author":"Sano","year":"2005","journal-title":"Nat. Med."},{"issue":"21","key":"10.1016\/j.lfs.2019.117115_bb0200","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1038\/sj.onc.1203551","article-title":"Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors","volume":"19","author":"Hirano","year":"2000","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.lfs.2019.117115_bb0205","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19010171","article-title":"Psoriasis: a STAT3-centric view","volume":"19","author":"Calautti","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.lfs.2019.117115_bb0210","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/jid.2010.255","article-title":"Stat3 as a therapeutic target for the treatment of psoriasis: a clinical feasibility study with STA-21, a Stat3 inhibitor","volume":"131","author":"Miyoshi","year":"2011","journal-title":"J. Invest. Dermatol."},{"issue":"10","key":"10.1016\/j.lfs.2019.117115_bb0215","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1038\/jid.2013.182","article-title":"NF-\u03baB and STAT3 inhibition as a therapeutic strategy in psoriasis: in vitro and in vivo effects of BTH","volume":"133","author":"Andr\u00e9s","year":"2013","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.lfs.2019.117115_bb0220","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/bjd.12271","article-title":"Mammalian target of rapamycin and its downstream signalling components are activated in psoriatic skin","volume":"169","author":"Buerger","year":"2013","journal-title":"Br. J. Dermatol."},{"issue":"7","key":"10.1016\/j.lfs.2019.117115_bb0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0180853","article-title":"Inflammation dependent mTORC1 signaling interferes with the switch from keratinocyte proliferation to differentiation","volume":"12","author":"Buerger","year":"2017","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.lfs.2019.117115_bb0230","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00281-009-0188-x","article-title":"Biology of interleukin-22","volume":"32","author":"Wolk","year":"2010","journal-title":"Semin. Immunopathol."},{"issue":"2","key":"10.1016\/j.lfs.2019.117115_bb0235","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/jcp.1041340208","article-title":"Biochemical and morphological characterization of growth and differentiation of normal human neonatal keratinocytes in a serum-free medium","volume":"134","author":"Pillai","year":"1988","journal-title":"J. Cell. Physiol."},{"issue":"2","key":"10.1016\/j.lfs.2019.117115_bb0240","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/med.21291","article-title":"Keratin 17: a critical player in the pathogenesis of psoriasis","volume":"34","author":"Jin","year":"2014","journal-title":"Med. Res. Rev."},{"issue":"1","key":"10.1016\/j.lfs.2019.117115_bb0245","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00281-015-0539-8","article-title":"Update on psoriasis immunopathogenesis and targeted immunotherapy","volume":"38","author":"Mahil","year":"2016","journal-title":"Semin. Immunopathol."},{"issue":"5","key":"10.1016\/j.lfs.2019.117115_bb0250","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJMra0804595","article-title":"Psoriasis","volume":"361","author":"Nestle","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.lfs.2019.117115_bb0255","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/jid.2009.59","article-title":"The IL-23\/Th17 axis in the immunopathogenesis of psoriasis","volume":"129","author":"Di Cesare","year":"2009","journal-title":"J. Invest. Dermatol."},{"issue":"6797","key":"10.1016\/j.lfs.2019.117115_bb0260","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/35021228","article-title":"Toll-like receptors in the induction of the innate immune response","volume":"406","author":"Aderem","year":"2000","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.lfs.2019.117115_bb0265","doi-asserted-by":"crossref","first-page":"943","DOI":"10.3233\/JAD-180330","article-title":"Diosgenin attenuates lipopolysaccharide-induced Parkinson\u2019s disease by inhibiting the TLR\/NF-\u03baB pathway","volume":"64","author":"Li","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.lfs.2019.117115_bb0270","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ejphar.2014.07.026","article-title":"Role of oxidative stress, inflammation, nitric oxide and transforming growth factor-beta in the protective effect of diosgenin in monocrotaline-induced pulmonary hypertension in rats","volume":"740","author":"Ahmed","year":"2014","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.lfs.2019.117115_bb0275","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1023\/A:1024515517623","article-title":"Angiogenesis in psoriasis","volume":"5","author":"Creamer","year":"2002","journal-title":"Angiogenesis"},{"issue":"4","key":"10.1016\/j.lfs.2019.117115_bb0280","first-page":"820","article-title":"Aberrant production of interleukin-8 and thrombospondin-1 by psoriatic keratinocytes mediates angiogenesis","volume":"144","author":"Nickoloff","year":"1994","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.lfs.2019.117115_bb0285","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0923-1811(94)90021-3","article-title":"Differential expression of transforming growth factor-alpha (TGF-alpha) and EGF receptor in transitional area of psoriatic epidermis","volume":"7","author":"Higashiyama","year":"1994","journal-title":"J. Dermatol. Sci."},{"issue":"1","key":"10.1016\/j.lfs.2019.117115_bb0290","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13073-017-0415-3","article-title":"Imiquimod has strain-dependent effects in mice and does not uniquely model human psoriasis","volume":"9","author":"Swindell","year":"2017","journal-title":"Genome Med."},{"issue":"6","key":"10.1016\/j.lfs.2019.117115_bb0295","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1038\/sj.jid.5700807","article-title":"Mouse models of psoriasis","volume":"127","author":"Gudjonsson","year":"2007","journal-title":"J. Invest. Dermatol."},{"issue":"12","key":"10.1016\/j.lfs.2019.117115_bb0300","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1002\/eji.201343801","article-title":"TLRs to cytokines: mechanistic insights from the imiquimod mouse model of psoriasis","volume":"43","author":"Flutter","year":"2013","journal-title":"Eur. J. Immunol."},{"issue":"9","key":"10.1016\/j.lfs.2019.117115_bb0305","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","article-title":"Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis","volume":"182","author":"van der Fits","year":"2009","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.lfs.2019.117115_bb0310","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1080\/17460441.2018.1463214","article-title":"Murine models of psoriasis and their usefulness for drug discovery","volume":"13","author":"Chuang","year":"2018","journal-title":"Expert Opin. Drug Discovery"},{"issue":"2","key":"10.1016\/j.lfs.2019.117115_bb0315","doi-asserted-by":"crossref","first-page":"171","DOI":"10.4062\/biomolther.2012.20.2.171","article-title":"HaCaT keratinocytes and primary epidermal keratinocytes have different transcriptional profiles of cornified envelope-associated genes to T helper cell cytokines","volume":"20","author":"Seo","year":"2012","journal-title":"Biomol. Ther. (Seoul)"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320519310422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320519310422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:32:25Z","timestamp":1758400345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320519310422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":63,"alternative-id":["S0024320519310422"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2019.117115","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The potential of Diosgenin in treating psoriasis: Studies from HaCaT keratinocytes and imiquimod-induced murine model","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2019.117115","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117115"}}